[Psycholytic psychotherapy].
D006801:Humans; D008238:Lysergic Acid Diethylamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001523:Mental Disorders / Q000628:therapy*; D011575:Psychoanalytic Therapy; D011577:Psychodrama; D011613:Psychotherapy; D011615:Psychotherapy, Group; D013808:Therapeutic Community
D008238:Lysergic Acid Diethylamide
Psycholytická psychoterapie.